Screener
Compass Therapeutics, Inc. CMPX Q1 2026 earnings
Reported May 5, 2026 · Before market open
EPS-$0.10In line
Revenue estimate-$818.2K
EPS estimate-$0.10
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$229.3K
EPS estimate-$0.12
Versus estimates
Diluted EPS
FAQ
- When did Compass Therapeutics, Inc. report Q1 2026 earnings?
- Compass Therapeutics, Inc. (CMPX) reported Q1 2026 earnings on May 5, 2026 before market open.
- What were Compass Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Compass Therapeutics, Inc. reported eps of $-0.10 for Q1 2026.
- Did Compass Therapeutics, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.10 by $0.00.
- How did Compass Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 16.7% from $-0.12.
- Where can I find Compass Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001171843-26-003005) and the 10-Q periodic report (0001171843-26-003006) directly on SEC EDGAR. The filing index links above go to sec.gov.
